Correction to: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway

J Exp Clin Cancer Res. 2021 Mar 30;40(1):115. doi: 10.1186/s13046-021-01923-9.

Gangjun Yuan^#^{1

2}, Xin Chen^#^{1

2}, Zhuowei Liu^#², Wensu Wei^{1

2}, Qinghai Shu³, Hussein Abou-Hamdan⁴, Lijuan Jiang¹, Xiangdong Li¹, Rixin Chen², Laurent Désaubry^{5

6}, Fangjian Zhou^{7

8}, Dan Xie⁹

¹ State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
² Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.
³ School of Material Science and Engineering, Beijing Institute of Technology, Beijing, China.
⁴ Therapeutic Innovation Laboratory, UMR7200, CNRS/University of Strasbourg, Strasbourg, France.
⁵ Therapeutic Innovation Laboratory, UMR7200, CNRS/University of Strasbourg, Strasbourg, France. [email protected].
⁶ Sino-French Joint Lab of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China. [email protected].
⁷ State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. [email protected].
⁸ Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China. [email protected].
⁹ State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. [email protected].

^# Contributed equally.

No abstract available

Publication types